Vor Biopharma Inc. (VOR) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Vor Biopharma Inc. (VOR) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

VOR Income Statement

Vor Biopharma Inc. (VOR) annual income statement — 8-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	28K	0	0	0	0	865K	0	900K	943K	892K	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-28K	0	0	0	0	-865K	0	-900K	-943K	-892K	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	100%	-	100%	100%	3.03%	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	47.85M	35.13M	35.96M	28.11M	274.28M	33.29M	30.45M	28.51M	28.14M	31.38M	27.23M	35.32M	32.17M	30.42M	24.73M	24.1M	21.79M	22.8M	18.31M	18.6M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	21.93M	17.54M	16.77M	14.42M	2.4M	6.59M	5.1M	6.7M	6.31M	7.06M	6.33M	7.71M	8.28M	8.51M	7.66M	7.23M	6.46M	7.52M	5.61M	5.68M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	25.92M	17.59M	19.19M	14.14M	261.5M	26.7M	25.35M	21.82M	21.82M	24.32M	20.9M	27.61M	23.9M	21.91M	17.06M	16.88M	15.33M	15.28M	12.69M	12.93M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	-451K	1000K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-47.85M	-35.16M	-35.96M	-28.11M	-274.28M	-33.29M	-31.31M	-28.51M	-29.04M	-32.33M	-28.12M	-35.32M	-32.17M	-30.42M	-24.73M	-24.1M	-21.79M	-22.8M	-18.31M	-18.6M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	82.55%	-5.61%	-14.85%	1.42%	-844.67%	-2.99%	-11.33%	19.26%	9.76%	-6.26%	-13.75%	-46.53%	-47.64%	-33.43%	-35.07%	-29.56%	-18.56%	-66.06%	-16.87%	-57.84%
EBITDA	-47.85M	-35.13M	-35.94M	-28.11M	-272.25M	-32.47M	-30.45M	-27.66M	-28.17M	-31.38M	-27.23M	-34.42M	-31.3M	-29.59M	-24.09M	-23.21M	-19.91M	-22.37M	-17.91M	-18.23M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	82.42%	-8.21%	-18.04%	-1.6%	-866.58%	-3.45%	-11.8%	19.64%	10.02%	-6.08%	-13.03%	-48.32%	-57.26%	-32.23%	-34.52%	-27.33%	-10.43%	-66.73%	-16.15%	-57.23%
D&A (Non-Cash Add-back)	0	28K	23K	2K	2.04M	825K	865K	851K	869K	943K	892K	893K	870K	837K	632K	892K	1.89M	426K	395K	374K
EBIT	-47.85M	-219.59M	1.72B	-812.68M	-243.55M	-32.49M	-30.71M	-27.56M	-27.84M	-30.8M	-26.26M	-35.32M	-32.17M	-30.42M	-24.73M	-24.1M	-21.79M	-22.8M	-18.31M	-18.6M
Net Interest Income	4.34M	3.94M	2.79M	1.73M	537K	805K	599K	954K	1.2M	1.52M	1.86M	2.13M	2.19M	1.99M	815K	313K	133K	63K	54K	48K
Interest Income	4.34M	3.94M	2.79M	1.73M	537K	805K	599K	954K	1.2M	1.52M	1.86M	2.13M	2.19M	1.99M	815K	313K	133K	63K	54K	48K
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	-14.96M	-184.43M	1.76B	-784.58M	-1.3B	805K	599K	954K	1.2M	1.52M	1.86M	2.13M	2.19M	1.99M	815K	313K	133K	63K	54K	48K
Pretax Income	-62.81M	-219.59M	1.72B	-812.68M	-1.57B	-32.49M	-30.71M	-27.56M	-27.84M	-30.8M	-26.26M	-33.19M	-29.98M	-28.43M	-23.91M	-23.79M	-21.66M	-22.74M	-18.25M	-18.55M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-62.81M	-219.59M	1.72B	-812.68M	-1.57B	-32.49M	-30.71M	-27.56M	-27.84M	-30.8M	-26.26M	-33.19M	-29.98M	-28.43M	-23.91M	-23.79M	-21.66M	-22.74M	-18.25M	-18.55M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	96.01%	-575.94%	5709.72%	-2848.89%	-5552.75%	-5.46%	-16.95%	16.97%	7.14%	-8.34%	-9.83%	-39.52%	-38.41%	-25.05%	-31%	-28.21%	-17.9%	-65.69%	-16.53%	-57.44%
Net Income (Continuing)	-62.81M	-219.59M	1.72B	-812.68M	-1.57B	-32.49M	-30.71M	-27.56M	-27.84M	-30.8M	-26.26M	-33.19M	-29.98M	-28.43M	-23.91M	-23.79M	-21.66M	-22.74M	-18.25M	-18.55M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.16	-510.53	44.50	-121.63	-251.20	-5.20	-9.00	-8.00	-8.20	-9.00	-7.80	-9.80	-9.00	-8.00	-9.80	-12.40	-11.40	-12.20	-9.80	-10.00
EPS Growth %	99.54%	-9717.88%	594.44%	-1420.38%	-2963.41%	42.22%	-15.38%	18.37%	8.89%	-12.5%	20.41%	20.97%	21.05%	34.43%	0%	-24%	-14%	1.61%	30%	48.45%
EPS (Basic)	-1.16	-510.53	307.53	-121.63	-251.20	-5.20	-9.00	-8.00	-8.20	-9.00	-7.80	-9.80	-9.00	-8.00	-9.80	-12.40	-11.40	-12.20	-9.80	-10.00
Diluted Shares Outstanding	54.3M	430.12K	9.87M	6.68M	6.26M	6.24M	3.44M	3.42M	3.41M	3.4M	3.39M	3.38M	3.35M	3.31M	2.32M	1.9M	1.87M	1.86M	1.85M	1.85M
Basic Shares Outstanding	54.3M	430.12K	9.87M	6.68M	6.26M	6.24M	3.44M	3.42M	3.41M	3.4M	3.39M	3.38M	3.35M	3.31M	2.32M	1.9M	1.87M	1.86M	1.85M	1.85M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-